Medicare Enrolled

Dr. Timothy Schoonover, D.O.

Neurology · Centerville, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1975 MIAMISBURG CENTERVILLE RD, Centerville, OH 45459
9374396186
In practice since 2005 (20 years)
NPI: 1033111802 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schoonover from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schoonover? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schoonover

Dr. Timothy Schoonover is a neurology specialist in Centerville, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Schoonover performed 60,879 Medicare services across 415 unique beneficiaries.

Between the years covered by Open Payments, Dr. Schoonover received a total of $408,067 from 84 pharmaceutical and/or device companies across 1603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schoonover is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in OH $408,067 industry payments

Medicare Practice Summary

Medicare Utilization ↗
60,879
Medicare services
Top 0% in OH for neurology
415
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,044 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
60,101 $5 $8
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
235 $132 $448
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
161 $93 $649
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 148 $55 $172
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
57 $137 $528
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
41 $4 $15
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $52 $125
Injection of anesthetic agent and/or steroid into other nerve or branch 39 $72 $299
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
36 $61 $128
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $76 $178
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$408,067
Total received (2018-2024)
Avg $58,295/year across 7 years
Top 2% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,603
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$393,148 (96.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,919 (3.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$20,551
2023
$26,694
2022
$60,704
2021
$92,320
2020
$44,687
2019
$101,745
2018
$61,366

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$18,142
UCB, Inc.
$334
Novartis Pharmaceuticals Corporation
$272
EMD Serono, Inc.
$248
Eisai Inc.
$192
PFIZER INC.
$167
Neurocrine Biosciences, Inc.
$163
SK Life Science, Inc.
$96
MDD US Operations, LLC
$88
JAZZ PHARMACEUTICALS INC.
$87
Alexion Pharmaceuticals, Inc.
$82
Lundbeck LLC
$79
Lilly USA, LLC
$73
Takeda Pharmaceuticals U.S.A., Inc.
$62
Amneal Pharmaceuticals LLC
$61
Genentech USA, Inc.
$55
ACADIA Pharmaceuticals Inc
$51
Teva Pharmaceuticals USA, Inc.
$51
ARGENX US, INC.
$45
Acorda Therapeutics, Inc
$32
Sandoz Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
GE HEALTHCARE
$22
Merz Pharmaceuticals, LLC
$19
Grifols USA, LLC
$19
Axsome Therapeutics, Inc.
$17
InSightec,Inc
$15
Ipsen Biopharmaceuticals, Inc
$14
Kyowa Kirin, Inc.
$13
Top 3 companies account for 91.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$134,661
Allergan, Inc.
$60,524
AbbVie Inc.
$58,883
ABBVIE INC.
$54,847
Teva Pharmaceuticals USA, Inc.
$48,032
Allergan Inc.
$36,247
Novartis Pharmaceuticals Corporation
$1,624
EMD Serono, Inc.
$846
Biogen, Inc.
$833
UCB, Inc.
$822
Supernus Pharmaceuticals, Inc.
$772
Alexion Pharmaceuticals, Inc.
$726
GENZYME CORPORATION
$565
Lilly USA, LLC
$546
Genentech USA, Inc.
$484
PFIZER INC.
$428
ACADIA Pharmaceuticals Inc
$410
Neurocrine Biosciences, Inc.
$389
Biohaven Pharmaceutical Holding Company Ltd.
$351
SK Life Science, Inc.
$339
Lundbeck LLC
$316
Biohaven Pharmaceuticals, Inc.
$312
MDD US Operations, LLC
$276
Acorda Therapeutics, Inc
$273
Janssen Pharmaceuticals, Inc
$261
Eisai Inc.
$249
Amneal Pharmaceuticals LLC
$244
InSightec,Inc
$214
Avanir Pharmaceuticals, Inc.
$211
Sunovion Pharmaceuticals Inc.
$202
JAZZ PHARMACEUTICALS INC.
$190
Ipsen Biopharmaceuticals, Inc
$160
Hyperfine Operations, Inc.
$156
ARGENX US, INC.
$153
Alnylam Pharmaceuticals Inc.
$132
Abbott Laboratories
$129
AbbVie, Inc.
$127
Adamas Pharmaceuticals, Inc.
$126
Takeda Pharmaceuticals U.S.A., Inc.
$121
Greenwich Biosciences, Inc.
$118
Kyowa Kirin, Inc.
$106
US WorldMeds, LLC
$102
Grifols USA, LLC
$84
AstraZeneca Pharmaceuticals LP
$84
CSL Behring
$84
TG THERAPEUTICS, INC.
$78
Medtronic USA, Inc.
$77
GE HealthCare
$73
Sumitomo Pharma America, Inc.
$66
Merz Pharmaceuticals, LLC
$64
EISAI INC.
$63
Neurelis, Inc.
$63
Octapharma USA, Inc.
$59
Merz North America, Inc.
$51
Impax Laboratories, Inc.
$38
PORTOLA PHARMACEUTICALS, INC.
$37
Promius Pharma LLC
$36
Amylyx Pharmaceuticals, Inc.
$36
Jazz Pharmaceuticals Inc.
$36
Mylan Pharmaceuticals Inc.
$35
Axsome Therapeutics, Inc.
$33
Upsher-Smith Laboratories LLC
$33
Currax Pharmaceuticals LLC
$32
Boston Scientific Corporation
$26
Mallinckrodt LLC
$26
Sandoz Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
Averitas Pharma Inc.
$25
Horizon Therapeutics plc
$23
Philips Electronics North America Corporation
$22
GE HEALTHCARE
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Otsuka America Pharmaceutical, Inc.
$21
Aprecia Pharmaceuticals, LLC
$21
Harmony Biosciences LLC
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$17
Cala Health, Inc.
$17
Mitsubishi Tanabe Pharma America, Inc.
$15
Medtronic Vascular, Inc.
$14
Corium, LLC
$13
Alfasigma USA, Inc.
$13
Assertio Therapeutics, Inc.
$12
HARMONY BIOSCIENCES LLC
$12
Egalet US Inc
$12
Top 3 companies account for 62.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA TRIO · COMIRNATY · CONTRAVE · COPAXONE · DAXXIFY · DUOPA · DYSPORT · Duopa · Dysport · EFFIENT · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Exablate · Fintepla · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · Kcentra · LEMTRADA · LYRICA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · ONZETRA XSAIL · Ocrevus · Ongentys · PANZYGA · PAXLOVID · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · RYTARY · Radicava · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SWOOP · Soliris · Spritam · Sunosi · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Wakix · XADAGO · XARELTO · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · Zembrace · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in OH.

Looking for a neurology specialist in Centerville?
Compare neurologists in the Centerville area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
61
Per 100K population
11.4
County median income
$64,403
Nearest hospital
KETTERING HEALTH MAIN CAMPUS
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schoonover is a mixed practice specialist, with above-average Medicare volume (top 0% in OH), with speaking/promotional industry engagement in the top 2% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schoonover experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Schoonover performed 60,101 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schoonover receive payments from pharmaceutical companies?
Yes. Dr. Schoonover received a total of $408,067 from 84 companies across 1,603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schoonover's costs compare to other neurologists in Centerville?
Dr. Schoonover's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schoonover) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →